Contrast-free (Zero-contrast) TAVR for Severe Aortic Stenosis in Patient with Chronic Kidney Disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) is a minimally invasive interventional procedure that repairs a valve without removing the old, damaged valve. Instead, a replacement valve is wedged into the location of the native aortic valve. During TAVR, contrast is used for conventional aortic root angiography, positioning of the TAVR valve device, and assessing the peripheral vasculature. Therefore, contrast-induced acute kidney injury (AKI) is a major concern when performing TAVR and is associated with increased mortality in patients with impaired renal function. Although the exact mechanism of post-TAVR AKI is unknown and appears multifactorial, contrast medium has been reported as a major contributing factor. We report a case of zero-contrast TAVR for severe AS in a patient with chronic kidney disease (CKD). The procedure was successfully performed with only fluoroscopic and transesophageal echocardiography (TEE) guidance.
Abstract
Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) is a minimally invasive interventional procedure that repairs a valve without removing the old, damaged valve. Instead, a replacement valve is wedged into the location of the native aortic valve. During TAVR, contrast is used for conventional aortic root angiography, positioning of the TAVR valve device, and assessing the peripheral vasculature. Therefore, contrast-induced acute kidney injury (AKI) is a major concern when performing TAVR and is associated with increased mortality in patients with impaired renal function. Although the exact mechanism of post-TAVR AKI is unknown and appears multifactorial, contrast medium has been reported as a major contributing factor. We report a case of zero-contrast TAVR for severe AS in a patient with chronic kidney disease (CKD). The procedure was successfully performed with only fluoroscopic and transesophageal echocardiography (TEE) guidance.
참고문헌 (11)
- Otto CM, "2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on clinical expert consensus documents", J Am Coll Cardiol, 69, pp.1313~1346 (2017)
- Eskandari M, "Zero contrast transfemoral transcatheter aortic valve replacement using fluoroscopy-echocardiography fusion imaging", Am J Cardiol, 117, pp.1861~1862 (2016)[DOI]
- Cheungpasitporn W, "Transcatheter aortic valve replacement: a kidney's perspective", J Renal Inj Prev, 5, pp.1~7 (2016)[DOI]
- Fassa AA, "Mechanisms and management of TAVR-related complications", Nat Rev Cardiol, 10, pp.685~695 (2013)[DOI]
- Scherner M, "Acute kidney injury after transcatheter aortic valve implantation", J Thorac Dis, 7, pp.1527~1535 (2015)
- Thongprayoon C, "Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis", Am J Nephrol, 41, pp.372~382 (2015)[DOI]
- Varga-Szemes A, "Non-contrast 3D radial and QISS MRA for transcatheter aortic valve replacement planning", J Cardiovasc Magn Reson, 17, pp.O71~ (2015)[DOI]
- Voigtlander L, "Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis", Int J Cardiol, 178, pp.275~281 (2015)[DOI]
- Bagur R, "Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement", Eur Heart J, 31, pp.865~874 (2010)[DOI]
- Barbash IM, "Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement", Am Heart J, 163, pp.1031~1036 (2012)[DOI]
- Bagur R, "Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation", JACC Cardiovasc Imaging, 4, pp.115~124 (2011)[DOI]